0001209191-13-041574.txt : 20130820
0001209191-13-041574.hdr.sgml : 20130820
20130820171826
ACCESSION NUMBER: 0001209191-13-041574
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160816
FILED AS OF DATE: 20130820
DATE AS OF CHANGE: 20130820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC
CENTRAL INDEX KEY: 0001008848
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
BUSINESS PHONE: 914-347-4300
MAIL ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COHEN RON
CENTRAL INDEX KEY: 0001272354
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50513
FILM NUMBER: 131051394
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-08-16
0
0001008848
ACORDA THERAPEUTICS INC
ACOR
0001272354
COHEN RON
420 SAW MILL RIVER ROAD
ARDSLEY
NY
10502
0
1
0
0
President and CEO
Common Stock
2013-08-16
4
M
0
19000
2.60
A
357090
D
Common Stock
2013-08-16
4
M
0
42062
2.60
A
399152
D
Common Stock
2013-08-16
4
S
0
61062
34.04
D
338090
D
Common Stock
2013-08-19
4
M
0
55993
2.60
A
394083
D
Common Stock
2013-08-19
4
S
0
55993
34.02
D
338090
D
Common Stock
2013-08-20
4
M
0
31945
2.60
A
370035
D
Common Stock
2013-08-20
4
S
0
26105
34.25
D
343930
D
Common Stock
2013-08-20
4
S
0
5840
34.82
D
338090
D
Common Stock
2013-08-20
4
M
0
19461
2.60
A
357551
D
Common Stock
2013-08-20
4
M
0
113141
2.60
A
470692
D
Common Stock
2013-08-20
4
M
0
8176
2.60
A
478868
D
Employee Stock Option (right to buy)
2.60
2013-08-16
4
M
0
19000
0.00
D
2013-10-17
Common Stock
19000
19461
D
Employee Stock Option (right to buy)
2.60
2013-08-16
4
M
0
42062
0.00
D
2013-09-11
Common Stock
42062
201079
D
Employee Stock Option (right to buy)
2.60
2013-08-19
4
M
0
55993
0.00
D
2013-09-11
Common Stock
55993
145086
D
Employee Stock Option (right to buy)
2.60
2013-08-20
4
M
0
31945
0.00
D
2013-09-11
Common Stock
31945
113141
D
Employee Stock Option (right to buy)
2.60
2013-08-20
4
M
0
19461
0.00
D
2013-10-17
Common Stock
19461
0
D
Employee Stock Option (right to buy)
2.60
2013-08-20
4
M
0
113141
0.00
D
2013-09-11
Common Stock
113141
0
D
Employee Stock Option (right to buy)
2.60
2013-08-20
4
M
0
8176
0.00
D
2013-09-11
Common Stock
8176
0
D
The stock options listed on Table I, Column 4 and Table II, Column 1 are being exercised because all of these options would otherwise expire in September and October of this year.
A total of 149,000 of the 289,778 shares issued upon exercise of these options have been sold, the proceeds of which are being used to fund the exercise of these options and the resulting tax liability. The sales referred to in Table I, Column 4 were made pursuant to a 10b5-1 plan.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $33.73 to $34.44 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $33.56 to $34.54 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $33.77 to $34.77 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $34.79 to $34.86 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The shares subject to these options vested in installments and were fully vested on April 17, 2005.
The shares subject to these options vested in installments and were fully vested on March 31, 2005.
/s/ Ron Cohen
2013-08-20